The global generic Drug market has witnessed a rapid growth in recent years. Some of the factors which have helped in the market growth of generic Drug are their performance characteristics, cost-effectiveness, reduced investments in R&D, patent expiry of the branded Drug, etc.
Request a Sample Report: https://www.imarcgroup.com/request?type=report&id=549&flag=B
The latest report by IMARC Group titled, “Generic $@!#% Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global generic $@!#% market reached a value of nearly US$ 230 Billion in 2016, growing at a CAGR of more than 8.5% during 2010-2016. Generic $@!#% have the same active ingredients and possess similar performance characteristics as their branded variants, such as strength, quality, form, effect, intended use, side effects, route of administration, therapeutic effect, etc. These $@!#% are manufactured under the same rules and regulations of manufacturing practices required for branded $@!#%. However, they are sold under their chemical names rather than the brand names.
Full Toc Report: https://www.imarcgroup.com/generic-drug-manufacturing-plant
Highlights of the global generic Drug market:
The market is driven primarily by their affordability.
The USA represents the largest market for these $@!#%, accounting for the majority of the share.
The market is expected to reach a value of around US$ 360 Billion by 2022.
The cost-effectiveness of the generic Drug has emerged as one of the major factors which has contributed in influencing the growth of the market. These rug require low investments in research & development, which brings down the cost of manufacturing significantly. This has encouraged the government and third-party payers to promote the manufacturing of these Drug and save billions of dollars on healthcare expenditures. Apart from this, the patent expiry of the branded Drug is also an essential factor which provides encouragement to the generic Drug market. Most branded Drug come with a lifespan of 20 years during which other manufacturers cannot sell the branded Drug under their companies’ name. However, when the patent protection expires, the manufacturing rights of these Drug is available to the other manufacturers. Some of the other growth inducing factors include rising aging-population, increasing prevalence of chronic diseases, and incentives offered to physicians and pharmacists to promote generics. Further, the market is expected to reach a value of nearly US$ 360 Billion by 2022.
The report has segmented the market on a regional basis. Some of the major markets for generic Drug include USA, China, Brazil, Germany and France. Amongst these, USA is the largest market, accounting for the majority of the share. An analysis of the competitive landscape provides the details of the key players operative in the market. Some of the major players are Teva Pharmaceuticals, Novartis–Sandoz, Mylan, Freseunis, and Hospira.
The report has examined the global generic Drug market on the basis of:
Novartis - Sandoz
Browse Related Report
Body Contouring Market: https://www.imarcgroup.com/body-contouring-market
Breast Pump Market: https://www.imarcgroup.com/breast-pump-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
- 0Avg Daily Vews
- 1 Day
- 1 Week
- 1 Month
- 2 Months
- 6 Months
- 1 Year